Abstract. This paper addresses the utilisation of fused deposition modelling (FDM) technology using polyamide 12, incorporated with bioceramic fillers (i.e. zirconia and hydroxyapatite) as a candidate for biomedical applications. The entire production process of printed PA12 is described, starting with compounding, filament wire fabrication and finally, FDM printing. The potential to process PA12 using this technique and mechanical, thermal and morphological properties were also examined. Commonly, a reduction of mechanical properties of printed parts would occur in comparison with injection moulded parts despite using the same material. Therefore, the mechanical properties of the samples prepared by injection moulding were also measured and applied as a benchmark to examine the effect of different processing methods. The results indicated that the addition of fillers improved or maintained the strength and stiffness of neat PA12, at the expense of reduced toughness and flexibility. Melting behaviours of PA12 were virtually insensitive to the processing techniques and were dependent on additional fillers and the cooling rate. Incorporation of fillers slightly lowered the melting temperature, however improved the thermal stability. In summary, PA12 composites were found to perform well with FDM technique and enabling the production of medical implants with acceptable mechanical performances for non-load bearing applications.
There was evidence for subtle upper spinal anomalies in the infant cleft lip and palate population. Our finding of reduced size of some cervical vertebral bodies may reflect delayed upper spinal development in infants with cleft lip and palate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.